Research progress and prospect of liver cirrhosis
10.3760/cma.j.cn501113-20210102-00002
- VernacularTitle:肝硬化研究进展和展望
- Author:
Jinghang XU
1
;
Yanyan YU
;
Xiaoyuan XU
Author Information
1. 北京大学第一医院感染疾病科 100034
- Keywords:
Liver cirrhosis;
Diagnosis;
Treatment;
Prevention
- From:
Chinese Journal of Hepatology
2021;29(2):108-110
- CountryChina
- Language:Chinese
-
Abstract:
Liver cirrhosis is the final stage of many chronic liver diseases, and is still a heavy disease burden. The proportion of liver cirrhosis caused by the hepatitis B virus is declining, while that caused by the non-alcoholic fatty liver disease (metabolic-associated fatty liver disease) is rising. Several predictive models and techniques such as transient elastography have been used for the early non-invasive evaluation of liver cirrhosis. Effective etiological treatment and complication management are the possible key to reverse and recompense liver function during liver cirrhosis treatment. In recent years, the effectiveness and availability of anti-hepatitis B and C virus drugs have been significantly improved, which provides the basis for effective etiological treatment of liver cirrhosis. However, there is still a lack of etiological treatment measures for non-alcoholic fatty liver disease. Therefore, in addition to focusing on common complications, we should also manage "rare" complications. This article reviews the changes in epidemiological characteristics, the update of the natural history concepts, diagnostic evaluation methods, and the treatment measures for liver cirrhosis.
